Owlet, Inc. (OWLT) 10-Year Financial Performance & Capital Metrics

OWLT • • Industrial / General

HealthcareMedical DevicesDiagnostic & Imaging EquipmentPoint-of-Care Diagnostics

AboutOwlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Smart Sock, a baby monitor to track an infant's oxygen levels, heart rates, and sleep trends; Dream Sock, an app to assist children for better sleep; Cam, a video streaming app to hear and see baby from anywhere; and Dream Lab, an interactive online platform that assists families in building healthy sleep habits. The company also offers Dream Duo, a monitoring system for baby's sleeping habits and includes wearable sock monitor, HD video, and digital sleep coach. Owlet, Inc. was founded in 2012 and is based in Lehi, Utah.Show more

Revenue $78M +44.5%
EBITDA -$19M +28.7%
Net Income -$13M +61.9%
EPS (Diluted) -0.83 +81.7%
Gross Margin 50.36% +20.4%
EBITDA Margin -24.14% +50.7%
Operating Margin -25.9% +51.1%
Net Margin -16.06% +73.6%
ROE -
ROIC -
Debt/Equity -
Interest Coverage -12.40 -38.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 95 (top 5%)
✓Efficient asset utilization: 1.6x turnover

✗Weaknesses

✗Negative free cash flow
✗Shares diluted 82.5% in last year

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y9.4%

3Y0.96%

TTM26.83%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-267.25%

EPS CAGR

10Y-

5Y-

3Y-

TTM-13.39%

ROCE

10Y Avg-325.28%

5Y Avg-259.85%

3Y Avg-302.32%

Latest-333.69%

Peer Comparison

Point-of-Care Diagnostics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
PAVMPAVmed Inc.	8.06M	8.75	17.64	22.15%	-217914.55%	-245.07%
SMLRSemler Scientific, Inc.	310.75M	20.33	3.96	-17.44%	130.8%	10.51%	0.00
BJDXBluejay Diagnostics, Inc.	1.18M	0.65	-0.02			-185.51%	0.04
HSCSHeartSciences Inc.	10.17M	3.20	-0.34	-76.61%	-1042.38%	-216.05%	14.55
LUCDLucid Diagnostics Inc.	163.87M	1.25	-1.19	79%	-8.6%	-404.1%	3.94
BMRABiomerica, Inc.	8.09M	2.68	-1.24	-1.92%	-90.29%	-90.76%	0.11
MDAISpectral AI, Inc.	49.41M	1.61	-1.89	63.83%	-70.64%
CODXCo-Diagnostics, Inc.	6.12M	2.92	-2.35	-42.53%	-63.36%	-80.8%	0.04

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	49.8M	75.4M	75.84M	69.2M	54.01M	78.06M
Revenue Growth %	-	0.51%	0.01%	-0.09%	-0.22%	0.45%
Cost of Goods Sold+	26.9M	39.53M	40.78M	45.89M	31.42M	38.75M
COGS % of Revenue	0.54%	0.52%	0.54%	0.66%	0.58%	0.5%
Gross Profit+	22.9M	35.88M	35.06M	23.31M	22.59M	39.31M
Gross Margin %	0.46%	0.48%	0.46%	0.34%	0.42%	0.5%
Gross Profit Growth %	-	0.57%	-0.02%	-0.34%	-0.03%	0.74%
Operating Expenses+	39.95M	42.87M	90.85M	107.93M	51.22M	59.53M
OpEx % of Revenue	0.8%	0.57%	1.2%	1.56%	0.95%	0.76%
Selling, General & Admin	28.49M	32.4M	69.42M	80.04M	40.87M	49.73M
SG&A % of Revenue	0.57%	0.43%	0.92%	1.16%	0.76%	0.64%
Research & Development	10.61M	10.46M	21.43M	27.9M	10.35M	9.8M
R&D % of Revenue	0.21%	0.14%	0.28%	0.4%	0.19%	0.13%
Other Operating Expenses	850K	0	0	0	0	0
Operating Income+	-17.05M	-6.99M	-55.79M	-84.62M	-28.63M	-20.22M
Operating Margin %	-0.34%	-0.09%	-0.74%	-1.22%	-0.53%	-0.26%
Operating Income Growth %	-	0.59%	-6.98%	-0.52%	0.66%	0.29%
EBITDA+	-16.51M	-6.12M	-54.66M	-81.95M	-26.42M	-18.84M
EBITDA Margin %	-0.33%	-0.08%	-0.72%	-1.18%	-0.49%	-0.24%
EBITDA Growth %	-	0.63%	-7.93%	-0.5%	0.68%	0.29%
D&A (Non-Cash Add-back)	544K	873K	1.13M	2.67M	2.21M	1.38M
EBIT	-17.05M	-9.12M	-43.84M	-78.2M	-29.7M	-10.85M
Net Interest Income+	694K	-1.38M	-27.83M	-1.1M	-3.19M	-1.63M
Interest Income	694K	0	0	0	0	0
Interest Expense	0	1.38M	27.83M	1.1M	3.19M	1.63M
Other Income/Expense	-801K	-3.51M	-15.88M	5.31M	-4.26M	7.74M
Pretax Income+	-17.85M	-10.5M	-71.67M	-79.31M	-32.89M	-12.48M
Pretax Margin %	-0.36%	-0.14%	-0.95%	-1.15%	-0.61%	-0.16%
Income Tax+	0	20K	31K	29K	10K	54K
Effective Tax Rate %	1%	1%	1%	1%	1%	1%
Net Income+	-17.85M	-10.52M	-71.7M	-79.34M	-32.9M	-12.54M
Net Margin %	-0.36%	-0.14%	-0.95%	-1.15%	-0.61%	-0.16%
Net Income Growth %	-	0.41%	-5.82%	-0.11%	0.59%	0.62%
Net Income (Continuing)	-17.85M	-10.52M	-71.7M	-79.34M	-32.9M	-12.54M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0
EPS (Diluted)+	-23.36	-5.12	-12.47	-9.97	-4.53	-0.83
EPS Growth %	-	0.78%	-1.44%	0.2%	0.55%	0.82%
EPS (Basic)	-23.36	-5.12	-12.47	-9.97	-4.53	-0.83
Diluted Shares Outstanding	764.22K	2.05M	7.87M	7.95M	8.28M	15.11M
Basic Shares Outstanding	764.22K	2.05M	7.87M	7.95M	8.28M	15.11M
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	25.61M	37.61M	135.81M	51.26M	39.94M	46.11M
Cash & Short-Term Investments	11.74M	17.01M	95.05M	11.23M	16.56M	20.25M
Cash Only	11.74M	17.01M	95.05M	11.23M	16.56M	20.25M
Short-Term Investments	0	0	0	0	0	0
Accounts Receivable	7.76M	10.53M	10.47M	15.96M	13.97M	12.14M
Days Sales Outstanding	56.91	50.95	50.38	84.17	94.43	56.75
Inventory	4.86M	7.91M	17.98M	18.52M	6.49M	10.52M
Days Inventory Outstanding	65.97	73.06	160.91	147.27	75.42	99.13
Other Current Assets	743K	0	0	0	1	386K
Total Non-Current Assets+	2.59M	2.5M	4.23M	6.84M	4.18M	3.4M
Property, Plant & Equipment	1.85M	1.72M	1.87M	3.37M	1.31M	240K
Fixed Asset Turnover	26.86x	43.89x	40.56x	20.55x	41.10x	325.23x
Goodwill	0	0	0	0	0	0
Intangible Assets	624K	605K	1.7M	2.28M	2.21M	975K
Long-Term Investments	0	-89.71K	0	0	0	0
Other Non-Current Assets	113K	181K	666K	1.2M	655K	2.19M
Total Assets+	28.2M	40.12M	140.05M	58.1M	44.12M	49.52M
Asset Turnover	1.77x	1.88x	0.54x	1.19x	1.22x	1.58x
Asset Growth %	-	0.42%	2.49%	-0.59%	-0.24%	0.12%
Total Current Liabilities+	24.93M	47.27M	69.09M	66.6M	45.09M	36.43M
Accounts Payable	8.11M	16.38M	27.77M	30.43M	13.68M	11.28M
Days Payables Outstanding	110.07	151.25	248.49	242.06	158.89	106.27
Short-Term Debt	8.75M	18.66M	8.53M	15.04M	15.19M	7.37M
Deferred Revenue (Current)	0	1000K	1000K	0	0	0
Other Current Liabilities	3.38M	0	0	8.62M	4.08M	2.31M
Current Ratio	1.03x	0.80x	1.97x	0.77x	0.89x	1.27x
Quick Ratio	0.83x	0.63x	1.71x	0.49x	0.74x	0.98x
Cash Conversion Cycle	12.81	-27.24	-37.19	-10.62	10.96	49.61
Total Non-Current Liabilities+	13.94M	13.67M	15.77M	2.14M	28.71M	34.23M
Long-Term Debt	13.51M	10.18M	7.99M	0	0	4.33M
Capital Lease Obligations	0	0	0	1.16M	22K	87K
Deferred Tax Liabilities	0	0	0	0	0	0
Other Non-Current Liabilities	437K	3.49M	7.77M	975K	28.69M	29.82M
Total Liabilities	38.87M	60.94M	84.86M	68.74M	73.8M	70.66M
Total Debt+	22.26M	28.84M	16.53M	18.3M	16.39M	11.87M
Net Debt	10.52M	11.83M	-78.53M	7.07M	-172K	-8.38M
Debt / Equity	-	-	0.30x	-	-	-
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-
Interest Coverage	-	-5.06x	-2.00x	-76.65x	-8.97x	-12.40x
Total Equity+	-10.67M	-20.82M	55.19M	-10.63M	-29.68M	-21.15M
Equity Growth %	-	-0.95%	3.65%	-1.19%	-1.79%	0.29%
Book Value per Share	-13.97	-10.14	7.01	-1.34	-3.59	-1.40
Total Shareholders' Equity	-10.67M	-20.82M	55.19M	-10.63M	-29.68M	-21.15M
Common Stock	1K	2K	11K	1K	1K	2K
Retained Earnings	-61.2M	-71.72M	-143.42M	-222.76M	-255.66M	-268.19M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-16.06M	-129K	-40.56M	-81.38M	-23.53M	-11.21M
Operating CF Margin %	-0.32%	-0%	-0.53%	-1.18%	-0.44%	-0.14%
Operating CF Growth %	-	0.99%	-313.39%	-1.01%	0.71%	0.52%
Net Income	-17.85M	-10.52M	-71.7M	-79.34M	-32.9M	-12.54M
Depreciation & Amortization	544K	873K	1.13M	2.67M	2.21M	1.38M
Stock-Based Compensation	595K	1.07M	4.26M	12.86M	9.93M	8.63M
Deferred Taxes	1.43M	0	0	0	0	0
Other Non-Cash Items	-1.16M	2.76M	16.3M	-2.37M	2.05M	-6.16M
Working Capital Changes	381K	5.69M	9.45M	-15.2M	-4.82M	-2.52M
Change in Receivables	-1.85M	-2.96M	-144K	-8.5M	965K	2.03M
Change in Inventory	-168K	-3.47M	-11.65M	-1.18M	12.12M	-4.14M
Change in Payables	0	11.82M	32.12M	-10.72M	-19.5M	1.32M
Cash from Investing+	-1.96M	-1.06M	-2.02M	-1.56M	-59K	-761K
Capital Expenditures	-1.56M	-967K	-969K	-636K	-16K	-35K
CapEx % of Revenue	0.03%	0.01%	0.01%	0.01%	0%	0%
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	-397K	-89K	-1.05M	-929K	-43K	-726K
Cash from Financing+	12.46M	6.46M	120.62M	-878K	28.91M	16.04M
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	3.85M	117K	124.11M	618K	269K	-2M
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	-17.62M	-1.19M	-42.58M	-82.94M	-23.59M	-11.97M
FCF Margin %	-0.35%	-0.02%	-0.56%	-1.2%	-0.44%	-0.15%
FCF Growth %	-	0.93%	-34.93%	-0.95%	0.72%	0.49%
FCF per Share	-23.06	-0.58	-5.41	-10.43	-2.85	-0.79
FCF Conversion (FCF/Net Income)	0.90x	0.01x	0.57x	1.03x	0.72x	0.89x
Interest Paid	0	0	1.77M	1.07M	1.88M	4.05M
Taxes Paid	0	0	0	0	11K	30K

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-417.25%	-356.12%	-	-
Gross Margin	45.99%	47.58%	46.23%	33.69%	41.82%	50.36%
Net Margin	-35.84%	-13.95%	-94.54%	-114.64%	-60.92%	-16.06%
Debt / Equity	-	-	0.30x	-	-	-
Interest Coverage	-	-5.06x	-2.00x	-76.65x	-8.97x	-12.40x
FCF Conversion	0.90x	0.01x	0.57x	1.03x	0.72x	0.89x
Revenue Growth	-	51.41%	0.58%	-8.76%	-21.95%	44.52%

Revenue by Geography

	2021	2022	2023	2024
UNITED STATES	65.44M	57.97M	46.36M	62.93M
UNITED STATES Growth	-	-11.42%	-20.02%	35.74%
Non-US	10.4M	11.23M	7.65M	9.94M
Non-US Growth	-	8.01%	-31.93%	30.00%

Frequently Asked Questions

Growth & Financials

Owlet, Inc. (OWLT) reported $99.7M in revenue for fiscal year 2024. This represents a 100% increase from $49.8M in 2019.

Owlet, Inc. (OWLT) grew revenue by 44.5% over the past year. This is strong growth.

Owlet, Inc. (OWLT) reported a net loss of $38.2M for fiscal year 2024.

Dividend & Returns

Owlet, Inc. (OWLT) had negative free cash flow of $7.5M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener

US Stock Screener

...

Owlet, Inc. (OWLT) 10-Year Financial Performance & Capital Metrics

OWLT • • Industrial / General

HealthcareMedical DevicesDiagnostic & Imaging EquipmentPoint-of-Care Diagnostics

Revenue $78M +44.5%
EBITDA -$19M +28.7%
Net Income -$13M +61.9%
EPS (Diluted) -0.83 +81.7%
Gross Margin 50.36% +20.4%
EBITDA Margin -24.14% +50.7%
Operating Margin -25.9% +51.1%
Net Margin -16.06% +73.6%
ROE -
ROIC -
Debt/Equity -
Interest Coverage -12.40 -38.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 95 (top 5%)
✓Efficient asset utilization: 1.6x turnover

✗Weaknesses

✗Negative free cash flow
✗Shares diluted 82.5% in last year

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y9.4%

3Y0.96%

TTM26.83%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-267.25%

EPS CAGR

10Y-

5Y-

3Y-

TTM-13.39%

ROCE

10Y Avg-325.28%

5Y Avg-259.85%

3Y Avg-302.32%

Latest-333.69%

Peer Comparison

Point-of-Care Diagnostics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
PAVMPAVmed Inc.	8.06M	8.75	17.64	22.15%	-217914.55%	-245.07%
SMLRSemler Scientific, Inc.	310.75M	20.33	3.96	-17.44%	130.8%	10.51%	0.00
BJDXBluejay Diagnostics, Inc.	1.18M	0.65	-0.02			-185.51%	0.04
HSCSHeartSciences Inc.	10.17M	3.20	-0.34	-76.61%	-1042.38%	-216.05%	14.55
LUCDLucid Diagnostics Inc.	163.87M	1.25	-1.19	79%	-8.6%	-404.1%	3.94
BMRABiomerica, Inc.	8.09M	2.68	-1.24	-1.92%	-90.29%	-90.76%	0.11
MDAISpectral AI, Inc.	49.41M	1.61	-1.89	63.83%	-70.64%
CODXCo-Diagnostics, Inc.	6.12M	2.92	-2.35	-42.53%	-63.36%	-80.8%	0.04

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	49.8M	75.4M	75.84M	69.2M	54.01M	78.06M
Revenue Growth %	-	0.51%	0.01%	-0.09%	-0.22%	0.45%
Cost of Goods Sold+	26.9M	39.53M	40.78M	45.89M	31.42M	38.75M
COGS % of Revenue	0.54%	0.52%	0.54%	0.66%	0.58%	0.5%
Gross Profit+	22.9M	35.88M	35.06M	23.31M	22.59M	39.31M
Gross Margin %	0.46%	0.48%	0.46%	0.34%	0.42%	0.5%
Gross Profit Growth %	-	0.57%	-0.02%	-0.34%	-0.03%	0.74%
Operating Expenses+	39.95M	42.87M	90.85M	107.93M	51.22M	59.53M
OpEx % of Revenue	0.8%	0.57%	1.2%	1.56%	0.95%	0.76%
Selling, General & Admin	28.49M	32.4M	69.42M	80.04M	40.87M	49.73M
SG&A % of Revenue	0.57%	0.43%	0.92%	1.16%	0.76%	0.64%
Research & Development	10.61M	10.46M	21.43M	27.9M	10.35M	9.8M
R&D % of Revenue	0.21%	0.14%	0.28%	0.4%	0.19%	0.13%
Other Operating Expenses	850K	0	0	0	0	0
Operating Income+	-17.05M	-6.99M	-55.79M	-84.62M	-28.63M	-20.22M
Operating Margin %	-0.34%	-0.09%	-0.74%	-1.22%	-0.53%	-0.26%
Operating Income Growth %	-	0.59%	-6.98%	-0.52%	0.66%	0.29%
EBITDA+	-16.51M	-6.12M	-54.66M	-81.95M	-26.42M	-18.84M
EBITDA Margin %	-0.33%	-0.08%	-0.72%	-1.18%	-0.49%	-0.24%
EBITDA Growth %	-	0.63%	-7.93%	-0.5%	0.68%	0.29%
D&A (Non-Cash Add-back)	544K	873K	1.13M	2.67M	2.21M	1.38M
EBIT	-17.05M	-9.12M	-43.84M	-78.2M	-29.7M	-10.85M
Net Interest Income+	694K	-1.38M	-27.83M	-1.1M	-3.19M	-1.63M
Interest Income	694K	0	0	0	0	0
Interest Expense	0	1.38M	27.83M	1.1M	3.19M	1.63M
Other Income/Expense	-801K	-3.51M	-15.88M	5.31M	-4.26M	7.74M
Pretax Income+	-17.85M	-10.5M	-71.67M	-79.31M	-32.89M	-12.48M
Pretax Margin %	-0.36%	-0.14%	-0.95%	-1.15%	-0.61%	-0.16%
Income Tax+	0	20K	31K	29K	10K	54K
Effective Tax Rate %	1%	1%	1%	1%	1%	1%
Net Income+	-17.85M	-10.52M	-71.7M	-79.34M	-32.9M	-12.54M
Net Margin %	-0.36%	-0.14%	-0.95%	-1.15%	-0.61%	-0.16%
Net Income Growth %	-	0.41%	-5.82%	-0.11%	0.59%	0.62%
Net Income (Continuing)	-17.85M	-10.52M	-71.7M	-79.34M	-32.9M	-12.54M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0
EPS (Diluted)+	-23.36	-5.12	-12.47	-9.97	-4.53	-0.83
EPS Growth %	-	0.78%	-1.44%	0.2%	0.55%	0.82%
EPS (Basic)	-23.36	-5.12	-12.47	-9.97	-4.53	-0.83
Diluted Shares Outstanding	764.22K	2.05M	7.87M	7.95M	8.28M	15.11M
Basic Shares Outstanding	764.22K	2.05M	7.87M	7.95M	8.28M	15.11M
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	25.61M	37.61M	135.81M	51.26M	39.94M	46.11M
Cash & Short-Term Investments	11.74M	17.01M	95.05M	11.23M	16.56M	20.25M
Cash Only	11.74M	17.01M	95.05M	11.23M	16.56M	20.25M
Short-Term Investments	0	0	0	0	0	0
Accounts Receivable	7.76M	10.53M	10.47M	15.96M	13.97M	12.14M
Days Sales Outstanding	56.91	50.95	50.38	84.17	94.43	56.75
Inventory	4.86M	7.91M	17.98M	18.52M	6.49M	10.52M
Days Inventory Outstanding	65.97	73.06	160.91	147.27	75.42	99.13
Other Current Assets	743K	0	0	0	1	386K
Total Non-Current Assets+	2.59M	2.5M	4.23M	6.84M	4.18M	3.4M
Property, Plant & Equipment	1.85M	1.72M	1.87M	3.37M	1.31M	240K
Fixed Asset Turnover	26.86x	43.89x	40.56x	20.55x	41.10x	325.23x
Goodwill	0	0	0	0	0	0
Intangible Assets	624K	605K	1.7M	2.28M	2.21M	975K
Long-Term Investments	0	-89.71K	0	0	0	0
Other Non-Current Assets	113K	181K	666K	1.2M	655K	2.19M
Total Assets+	28.2M	40.12M	140.05M	58.1M	44.12M	49.52M
Asset Turnover	1.77x	1.88x	0.54x	1.19x	1.22x	1.58x
Asset Growth %	-	0.42%	2.49%	-0.59%	-0.24%	0.12%
Total Current Liabilities+	24.93M	47.27M	69.09M	66.6M	45.09M	36.43M
Accounts Payable	8.11M	16.38M	27.77M	30.43M	13.68M	11.28M
Days Payables Outstanding	110.07	151.25	248.49	242.06	158.89	106.27
Short-Term Debt	8.75M	18.66M	8.53M	15.04M	15.19M	7.37M
Deferred Revenue (Current)	0	1000K	1000K	0	0	0
Other Current Liabilities	3.38M	0	0	8.62M	4.08M	2.31M
Current Ratio	1.03x	0.80x	1.97x	0.77x	0.89x	1.27x
Quick Ratio	0.83x	0.63x	1.71x	0.49x	0.74x	0.98x
Cash Conversion Cycle	12.81	-27.24	-37.19	-10.62	10.96	49.61
Total Non-Current Liabilities+	13.94M	13.67M	15.77M	2.14M	28.71M	34.23M
Long-Term Debt	13.51M	10.18M	7.99M	0	0	4.33M
Capital Lease Obligations	0	0	0	1.16M	22K	87K
Deferred Tax Liabilities	0	0	0	0	0	0
Other Non-Current Liabilities	437K	3.49M	7.77M	975K	28.69M	29.82M
Total Liabilities	38.87M	60.94M	84.86M	68.74M	73.8M	70.66M
Total Debt+	22.26M	28.84M	16.53M	18.3M	16.39M	11.87M
Net Debt	10.52M	11.83M	-78.53M	7.07M	-172K	-8.38M
Debt / Equity	-	-	0.30x	-	-	-
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-
Interest Coverage	-	-5.06x	-2.00x	-76.65x	-8.97x	-12.40x
Total Equity+	-10.67M	-20.82M	55.19M	-10.63M	-29.68M	-21.15M
Equity Growth %	-	-0.95%	3.65%	-1.19%	-1.79%	0.29%
Book Value per Share	-13.97	-10.14	7.01	-1.34	-3.59	-1.40
Total Shareholders' Equity	-10.67M	-20.82M	55.19M	-10.63M	-29.68M	-21.15M
Common Stock	1K	2K	11K	1K	1K	2K
Retained Earnings	-61.2M	-71.72M	-143.42M	-222.76M	-255.66M	-268.19M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-16.06M	-129K	-40.56M	-81.38M	-23.53M	-11.21M
Operating CF Margin %	-0.32%	-0%	-0.53%	-1.18%	-0.44%	-0.14%
Operating CF Growth %	-	0.99%	-313.39%	-1.01%	0.71%	0.52%
Net Income	-17.85M	-10.52M	-71.7M	-79.34M	-32.9M	-12.54M
Depreciation & Amortization	544K	873K	1.13M	2.67M	2.21M	1.38M
Stock-Based Compensation	595K	1.07M	4.26M	12.86M	9.93M	8.63M
Deferred Taxes	1.43M	0	0	0	0	0
Other Non-Cash Items	-1.16M	2.76M	16.3M	-2.37M	2.05M	-6.16M
Working Capital Changes	381K	5.69M	9.45M	-15.2M	-4.82M	-2.52M
Change in Receivables	-1.85M	-2.96M	-144K	-8.5M	965K	2.03M
Change in Inventory	-168K	-3.47M	-11.65M	-1.18M	12.12M	-4.14M
Change in Payables	0	11.82M	32.12M	-10.72M	-19.5M	1.32M
Cash from Investing+	-1.96M	-1.06M	-2.02M	-1.56M	-59K	-761K
Capital Expenditures	-1.56M	-967K	-969K	-636K	-16K	-35K
CapEx % of Revenue	0.03%	0.01%	0.01%	0.01%	0%	0%
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	-397K	-89K	-1.05M	-929K	-43K	-726K
Cash from Financing+	12.46M	6.46M	120.62M	-878K	28.91M	16.04M
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	3.85M	117K	124.11M	618K	269K	-2M
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	-17.62M	-1.19M	-42.58M	-82.94M	-23.59M	-11.97M
FCF Margin %	-0.35%	-0.02%	-0.56%	-1.2%	-0.44%	-0.15%
FCF Growth %	-	0.93%	-34.93%	-0.95%	0.72%	0.49%
FCF per Share	-23.06	-0.58	-5.41	-10.43	-2.85	-0.79
FCF Conversion (FCF/Net Income)	0.90x	0.01x	0.57x	1.03x	0.72x	0.89x
Interest Paid	0	0	1.77M	1.07M	1.88M	4.05M
Taxes Paid	0	0	0	0	11K	30K

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-417.25%	-356.12%	-	-
Gross Margin	45.99%	47.58%	46.23%	33.69%	41.82%	50.36%
Net Margin	-35.84%	-13.95%	-94.54%	-114.64%	-60.92%	-16.06%
Debt / Equity	-	-	0.30x	-	-	-
Interest Coverage	-	-5.06x	-2.00x	-76.65x	-8.97x	-12.40x
FCF Conversion	0.90x	0.01x	0.57x	1.03x	0.72x	0.89x
Revenue Growth	-	51.41%	0.58%	-8.76%	-21.95%	44.52%

Revenue by Geography

	2021	2022	2023	2024
UNITED STATES	65.44M	57.97M	46.36M	62.93M
UNITED STATES Growth	-	-11.42%	-20.02%	35.74%
Non-US	10.4M	11.23M	7.65M	9.94M
Non-US Growth	-	8.01%	-31.93%	30.00%

Frequently Asked Questions

Growth & Financials

Owlet, Inc. (OWLT) reported $99.7M in revenue for fiscal year 2024. This represents a 100% increase from $49.8M in 2019.

Owlet, Inc. (OWLT) grew revenue by 44.5% over the past year. This is strong growth.

Owlet, Inc. (OWLT) reported a net loss of $38.2M for fiscal year 2024.

Dividend & Returns

Owlet, Inc. (OWLT) had negative free cash flow of $7.5M in fiscal year 2024, likely due to heavy capital investments.